BCLI
Commonwealth Equity Services’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-14,258
| Closed | -$241K | – | 3204 |
|
2020
Q3 | $241K | Buy |
+14,258
| New | +$241K | ﹤0.01% | 2546 |
|
2020
Q1 | – | Sell |
-11,866
| Closed | -$50K | – | 2826 |
|
2019
Q4 | $50K | Buy |
11,866
+100
| +0.8% | +$421 | ﹤0.01% | 2801 |
|
2019
Q3 | $45K | Hold |
11,766
| – | – | ﹤0.01% | 2747 |
|
2019
Q2 | $46K | Hold |
11,766
| – | – | ﹤0.01% | 2701 |
|
2019
Q1 | $51K | Hold |
11,766
| – | – | ﹤0.01% | 2658 |
|
2018
Q4 | $41K | Hold |
11,766
| – | – | ﹤0.01% | 2578 |
|
2018
Q3 | $44K | Hold |
11,766
| – | – | ﹤0.01% | 2702 |
|
2018
Q2 | $46K | Hold |
11,766
| – | – | ﹤0.01% | 2663 |
|
2018
Q1 | $37K | Hold |
11,766
| – | – | ﹤0.01% | 2615 |
|
2017
Q4 | $46K | Buy |
11,766
+500
| +4% | +$1.96K | ﹤0.01% | 2573 |
|
2017
Q3 | $46K | Hold |
11,266
| – | – | ﹤0.01% | 2473 |
|
2017
Q2 | $47K | Buy |
+11,266
| New | +$47K | ﹤0.01% | 2422 |
|